Harrow (HROW) News Today → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free HROW Stock Alerts $12.08 +0.48 (+4.14%) (As of 02:07 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHarrow Names Greg DiPasquale as Senior Vice President, Head of Commercialbusinesswire.com - May 13 at 7:00 AMHarrow (HROW) Scheduled to Post Earnings on Mondayamericanbankingnews.com - May 11 at 1:04 AMAnalysts Offer Insights on Healthcare Companies: Rapid Micro Biosystems (RPID), COMPASS Pathways (CMPS) and Harrow Health (HROW)markets.businessinsider.com - May 10 at 4:03 PMHarrow Health (HROW) Scheduled to Post Quarterly Earnings on Mondaymarketbeat.com - May 6 at 8:45 AMHarrow: Merits A Buy On Sales Potentialseekingalpha.com - May 2 at 1:06 PMHarrow: The Bull Thesis Is On Track, But Short-Term Challenges Loomseekingalpha.com - May 2 at 7:37 AMHarrow Health, Inc. (NASDAQ:HROW) Major Shareholder Purchases $199,400.00 in Stockinsidertrades.com - April 26 at 6:11 AMInsider Buying: Harrow Health, Inc. (NASDAQ:HROW) Major Shareholder Buys 20,000 Shares of Stockmarketbeat.com - April 25 at 7:40 PMHarrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024businesswire.com - April 25 at 7:00 AMOpaleye Management Inc. Purchases 11,715 Shares of Harrow Health, Inc. (NASDAQ:HROW) Stockinsidertrades.com - April 25 at 6:22 AMHarrow Health, Inc. (NASDAQ:HROW) Major Shareholder Opaleye Management Inc. Purchases 11,715 Sharesmarketbeat.com - April 24 at 6:39 PMOpaleye Management Inc. Acquires 29,400 Shares of Harrow Health, Inc. (NASDAQ:HROW) Stockinsidertrades.com - April 21 at 4:48 AMHarrow, Inc. (HROW)finance.yahoo.com - April 20 at 7:57 PMInsider Buying: Harrow Health, Inc. (NASDAQ:HROW) Major Shareholder Purchases 29,400 Shares of Stockmarketbeat.com - April 19 at 9:12 PMVanguard Group Inc. Has $25.29 Million Stock Holdings in Harrow Health, Inc. (NASDAQ:HROW)marketbeat.com - April 13 at 4:31 AMHarrow Health (NASDAQ:HROW) Now Covered by Craig Hallummarketbeat.com - April 11 at 8:12 AMMelt Pharmaceuticals raises $24 million for drug developmentbizjournals.com - April 3 at 11:23 PMMelt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financingfinance.yahoo.com - April 2 at 9:50 AMOpaleye Management Inc. Acquires 50,000 Shares of Harrow Health, Inc. (NASDAQ:HROW) Stockinsidertrades.com - March 29 at 8:23 AMHarrow Health, Inc. (NASDAQ:HROW) Major Shareholder Purchases $641,000.00 in Stockmarketbeat.com - March 28 at 7:28 PMMark L. Baum Acquires 9,000 Shares of Harrow Health, Inc. (NASDAQ:HROW) Stockinsidertrades.com - March 26 at 4:44 AMInsider Buying: Harrow Health, Inc. (NASDAQ:HROW) CEO Acquires 9,000 Shares of Stockmarketbeat.com - March 25 at 11:31 AMB. Riley Cuts Harrow Health (NASDAQ:HROW) Price Target to $26.00marketbeat.com - March 25 at 8:09 AMOpaleye Management Inc. Acquires 50,600 Shares of Harrow Health, Inc. (NASDAQ:HROW) Stockinsidertrades.com - March 23 at 8:49 AMHarrow Health, Inc. (NASDAQ:HROW) Major Shareholder Opaleye Management Inc. Buys 50,600 Sharesmarketbeat.com - March 22 at 2:11 PMHarrow Health, Inc. (NASDAQ:HROW) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 21 at 5:33 PMWhy Is Harrow (HROW) Stock Up 5% Today?investorplace.com - March 20 at 8:34 AMHarrow Health Non-GAAP EPS of -$0.20 misses by $0.15, revenue of $36.36M misses by $1.5Mmsn.com - March 20 at 4:57 AMHROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q4 2023investorplace.com - March 19 at 11:07 PMHarrow Inc (HROW) Reports Substantial Revenue Growth Amidst Net Loss Expansion in 2023finance.yahoo.com - March 19 at 7:18 PMHarrow Announces Fourth Quarter and Year-End 2023 Financial Resultsbusinesswire.com - March 19 at 5:45 PMShort Interest in Harrow Health, Inc. (NASDAQ:HROW) Expands By 9.1%marketbeat.com - March 18 at 11:13 PMEarnings Preview: Harrow Healthbenzinga.com - March 18 at 1:07 PMHarrow (HROW) Fell on Lowering the Guidancefinance.yahoo.com - March 13 at 8:22 AMKennedy Capital Management LLC Acquires Shares of 121,808 Harrow Health, Inc. (NASDAQ:HROW)marketbeat.com - March 10 at 6:54 AMHarrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024finance.yahoo.com - March 5 at 8:31 AMStifel Financial Corp Buys New Position in Harrow Health, Inc. (NASDAQ:HROW)marketbeat.com - March 4 at 5:44 AMHarrow Health, Inc. (NASDAQ:HROW) Shares Acquired by Braidwell LPmarketbeat.com - March 1 at 10:18 AMHere’s How Harrow (HROW) Weighed on SRK Capital’s Performancefinance.yahoo.com - February 29 at 2:13 AMHarrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Productsbusinesswire.com - February 15 at 4:01 PMJump Financial LLC Invests $1.04 Million in Harrow Health, Inc. (NASDAQ:HROW)marketbeat.com - February 6 at 5:20 AMRice Hall James & Associates LLC Purchases Shares of 250,380 Harrow Health, Inc. (NASDAQ:HROW)marketbeat.com - January 21 at 8:48 AMHarrow says dry eye drug Vevye now available in USmsn.com - January 11 at 1:35 PMHarrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Diseasefinance.yahoo.com - January 11 at 8:34 AMHarrow Inc. partners with technology companies for dry eye prescription Vevyebizjournals.com - January 3 at 4:40 PMShort Interest in Harrow Health, Inc. (NASDAQ:HROW) Drops By 20.0%marketbeat.com - December 15 at 9:40 AMHarrow Health’s Strong Sales Growth and Strategic Acquisitions Fuel Buy Ratingmarkets.businessinsider.com - December 9 at 7:47 AMHarrow Completes Transfer of the TRIESENCE® New Drug Applicationfinance.yahoo.com - November 29 at 8:24 AMHROWM Harrow Health, Inc. NT CAL 27seekingalpha.com - November 24 at 10:51 PMHarrow to Present at Two Investor Conferences in Novemberfinance.yahoo.com - November 20 at 8:01 AM Get Harrow News Delivered to You Automatically Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter. Email Address He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here HROW Media Mentions By Week HROW Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HROW News Sentiment▼0.480.58▲Average Medical News Sentiment HROW News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HROW Articles This Week▼52▲HROW Articles Average Week Get Harrow News Delivered to You Automatically Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Erasca News Mereo BioPharma Group News Rani Therapeutics News ADC Therapeutics News Amarin News Terns Pharmaceuticals News Alto Neuroscience News Nature's Sunshine Products News Corbus Pharmaceuticals News Mersana Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HROW) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldUrgent Nvidia WarningAltimetryConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harrow, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
